Generic Pharmaceuticals Market 2022 – By Therapy (CNS, Cardiovascular, Dermatology, Genitourinary/Harmonal, Respiratory, Rheumatology, Diabetes, Oncology, Biosimilars), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, And Online Pharmacies), By Type (Biosimilars, Generics), By Drug Delivery (Oral, Injectables, Dermal/Topical, Inhaled), And By Region, Opportunities And Strategies – Global Forecast To 2030

Starting Price : $5000.00 | Pages : 305 | Published : June 2022 | | Format : pdf

Purchase Options
Request Sample
Request For Discount

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Generic Pharmaceuticals Market Definition

The generic pharmaceuticals market consists of the sales of generic pharmaceuticals and relates to services by entities (organizations, sole traders, or partnerships) that produce generic pharmaceuticals including biosimilars.

Generic pharmaceuticals are copies of known brand-name drugs that have exactly the same dosage, intended use, effects, side effects, route of administration, risks, safety, and strength as the original drug. Their pharmacological effects are exactly the same as those of their brand-name counterparts. An example of a generic drug used for diabetes, is Metformin. The brand name for Metformin is Glucophage. A generic drug used for Hypertension, is Metoprolol, whereas the brand name for the same drug is Lopressor.

Generic Pharmaceuticals Market Size

The global generic pharmaceuticals market size reached a value of nearly $185,983.4 million in 2020 to $258,162.8 million in 2025 at a rate of 6.8%. The global generic pharmaceuticals market size is then expected to grow at a CAGR of 7.4% from 2025 and reach $369,152.8 million in 2030.  

Growth in the historic period resulted from rise in healthcare awareness and expenditure, patent expiration of drugs, increased prevalence of respiratory diseases, changes in lifestyles, increased number of surgical procedures, strong economic growth in emerging markets, increase in insurance coverage, rapid growth in elderly population, increased number of approvals. Factors that negatively affected growth in the historic period were lack of awareness about generic drugs, challenges due to regulatory changes, and low healthcare access.

Growth in the forecast period resulted from increasing rising incidence of chronic diseases, rising regulators support, new methods for drug discovery, new methods for drug delivery and monitoring, rise in healthcare expenditure, increasing geriatric population, and major drug patents. Factors that negatively affected growth in the forecast period were adverse effects associated with the drugs, rising popularity of alternative therapies and natural remedies, coronavirus pandemic, and low per capita healthcare expenditure.

Generic Pharmaceuticals Market Drivers

The key drivers of the generic pharmaceuticals market include:

Rising Incidence Of Chronic Diseases

The rising incidence of chronic diseases is one of the major drivers of the generic pharmaceuticals market. As more individuals are diagnosed with chronic diseases, they look for more medicines for treatment. Branded drugs come at a premium price, while generic drugs are available at a lower cost having the same chemical composition as branded drugs. The low cost and same chemical composition and strength of generic drugs make a patient buy generic drugs instead of branded drugs. If it is a chronic disease, the treatment goes on for a longer period, and hence, the sales of generic drugs also increase. For instance, according to the WHO (World Health Organization), over the next 10 years, deaths due to chronic disease is projected to increase by 17%. Also, in 2020, almost 3-quarters of all deaths in the world are due to chronic diseases.

Generic Pharmaceuticals Market Restraints

The key restraints on the generic pharmaceuticals market include:

Adverse Effects Associated With The Drugs

Adverse effects associated with generic pharmaceutical drugs are expected to restrain the market growth in the forecast period. Although generics have so far been shown to be as effective and safe as branded drugs, there is a concern that they are more likely than brand-name medications to be the target of adulteration with toxic substances, because some companies might be tempted to cut corners in efforts to keep them as cheap as possible. For instance, according to a study published in June 2021 by the University Of British Colombia, contaminants in generic medications used to treat conditions like diabetes, heart disease, stomach aches, and heartburn may cause damage to DNA, affect basic cell functions, and even increase a person’s risk of cancer. Thus, the risk of adverse effects associated with generic pharmaceutical drugs limits the growth of the market.

Generic Pharmaceuticals Market Trends

Major trends influencing the generic pharmaceuticals market include:

Use of Biomarkers for Drug Development

Generic pharmaceutical companies are increasingly using biomarkers in the drug development process to reduce the time taken to bring the product into the market. Biomarkers are biological indicators that are objectively measured and evaluated for biological processes, pathogenic processes, or pharmacological responses to a therapeutic intervention. They are helpful to predict the drug efficacy faster than conventional clinical endpoints, the point at which an undesired or abnormal effect of the drug is observed indicating withdrawal from therapy. Companies in this market are investing in the development of biomarkers for use in various activities such as tracking drug activity, studying pharmacodynamics (relationship between the drug concentration at the site of action and the biochemical and physiological effect) of drugs, and studying diseases and treatment pathways. Companies such as Genentech and Janssen are increasingly investing in the use of biomarkers for understanding the efficacy of a potential respiratory drug.  For example, Janssen has a partnership with U-BIOPRED (unbiased biomarkers in the prediction of respiratory disease outcomes), a group in Europe that aims to understand more about severe asthma.

New Product Launches

The launch of new generic pharmaceutical drugs by major companies is a positive trend in the market. Due to the highly competitive nature of the market and the presence of various players, companies are focusing on new advanced drugs to manufacture generic pharmaceuticals drugs for various applications. For instance, in November 2021, Beximco Pharmaceuticals, a Bangladesh-based pharmaceuticals company announced the launch of the world’s first generic molnupiravir, an oral antiviral drug for the treatment of patients with mild to moderate forms of COVID-19 that were recently developed by the U.S. firms Merck, Sharp & Dohme (MSD) and Ridgeback Biotherapeutics. The drug molnupiravir is a major achievement in bringing forward breakthrough medicines to address the world’s current greatest health challenge.  Similarly, in September 2021, Indian pharmaceutical companies, Dr. Reddy's Laboratories, and Natco Pharma announced the launch of generic capsules used in the treatment of multiple myeloma and myelodysplastic syndrome patients in the Canadian market.  Innovation focused companies in the market are supported by the regulatory authorities in the launch of innovative and research-oriented products to help the growing patient population.

Opportunities And Recommendations In The Generic Pharmaceuticals Market

Opportunities –The top opportunities in the generic pharmaceuticals market segmented by therapy will arise in the others segment, which will gain $26,279.5 million of global annual sales by 2025. The top opportunities in the generic pharmaceuticals market segmented by distribution channel will arise in hospital pharmacies segment, which will gain $35,869.5 million of global annual sales by 2025. The top opportunities in the generic pharmaceuticals market segmented by type will arise in generics segment, which will gain $59,757.6 million of global annual sales by 2025. The top opportunities in the generic pharmaceuticals market segmented by drug delivery will arise in oral segment, which will gain $37,872.1 million of global annual sales by 2025.  The generic pharmaceuticals market size will gain the most in the USA at $27,996.3 million.

Recommendations-To take advantage of these opportunities, The Business Research Company recommends the generic pharmaceutical companies to focus on use of biomarkers for drug development, focus on 3D printing technology, focus on rise of generic respiratory drugs, invest in artificial intelligence, set up authorized distributors and sales representatives, focus on competitive pricing, increase adoption of internet and social media, targeting hospitals and pharmacies to spread awareness.

Generic Pharmaceuticals Market Segmentation

The generic pharmaceuticals market is segmented by therapy, by distribution channel, by type, by drug delivery.
By Therapy –
The generic pharmaceuticals market is segmented by therapy into
    • a) CNS
    • b) Cardiovascular
    • c) Dermatology
    • d) Genitourinary/Harmonal
    • e) Respiratory
    • f) Rheumatology
    • g) Diabetes
    • h) Oncology
    • i) Biosimilars
    • j) Others
The others segment of the generic pharmaceuticals market accounted for $75,619.5 million in 2020 and expected to reach a value of $101,899.1 million by 2025, at a CAGR of 6.1%. Biosimilars segment is expected to be the fastest growing segment in the generic pharmaceuticals market segmented by therapy, going forward, at a CAGR of 17.8% during 2020-2025.
By Distribution Channel –
The generic pharmaceuticals market is segmented by distribution channel into.
    • a) Hospital Pharmacies
    • b) Retail Pharmacies
    • c) Online Pharmacies
The hospital pharmacies segment of the generic pharmaceuticals market accounted for $92,478.5 million in 2020 and expected to reach a value of $128,348.0 million by 2025, at a CAGR of 6.8%. Online pharmacies segment is expected to be the fastest growing segment in the generic pharmaceuticals market segmented by therapy, going forward, at a CAGR of 9.1% during 2020-2025.
By Type –
The generic pharmaceuticals market is segmented by type into.
    • a) Biosimilar
    • b) Generics
The generics segment of the generic pharmaceuticals market accounted for $176,191.5 million in 2020 and expected to reach a value of $235,949.1 million by 2025, at a CAGR of 6.0%. Biosimilars segment is expected to be the fastest growing segment in the generic pharmaceuticals market segmented by therapy, going forward, at a CAGR of 17.8% during 2020-2025.
By Drug Delivery –
The generic pharmaceuticals market is segmented by drug delivery into.
    • a) Oral
    • b) Injectables
    • c) Dermal/Topical
    • d) Inhaled
The oral segment of the generic pharmaceuticals market accounted for $104,434.0 million in 2020 and expected to reach a value of $142,306.2 million by 2025, at a CAGR of 6.4%. Dermal/Topical segment is expected to be the fastest growing segment in the generic pharmaceuticals market segmented by therapy, going forward, at a CAGR of 8.2% during 2020-2025.
By Geography – The generic pharmaceuticals market is segmented by geography into
      o Asia Pacific
      • • Australia
      • • China
      • • Japan
      • • India
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
North America was the largest region in the global generic pharmaceuticals market, accounting for 48.3% of the total in 2020. It was followed by Asia-Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the global generic pharmaceuticals market will be South America and Middle East, where growth will be at CAGRs of 10.1% and 9.4% respectively during 2020-2025. These will be followed by Africa and Asia Pacific, where the markets are expected to grow at CAGRs of 9.1% and 7.8% respectively during 2020-2025.

Generic Pharmaceuticals Market Competitive Landscape

Major Competitors are:

  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd.
  • Fresenius Kabi
  • Aurobindo Pharma Limited

    • Other Competitors Include:

  • Cipla Limited
  • Stada Arzneimittel AG
  • Lupin Pharmaceuticals, Inc.
  • Dr. Reddy's Laboratories
  • Mylan Inc.
  • Shanghai Generic Pharmaceuticals
  • Shanghai Acebright Generic Pharmaceuticals Group Co., Ltd.
  • Sandoz
  • Glenmark
  • Kent Pharma
  • GlaxoSmithKline (GSK)
  • Zentiva
  • Sanofi
  • Merck & Co.
  • Apotex
  • Pfizer
  • Gilead Sciences
  • Roche
  • Bayer
  • AbbVie Inc.
  • AstraZeneca
  • Amgen
  • Abbott Laboratories
  • Janssen Pharmaceutica
  • Accord Healthcare Inc.
  • Acerus Pharmaceutical Drugs Corporation
  • AA Pharma Inc
  • Sanfer
  • LABORATORIOS SENOSIAIN SA DE CV (Senosiain)
  • Siegfried Rhein
  • Johnson and Johnson
  • Bristol Myers Squibb
  • Eli Lilly & Company
  • Biogen
  • EMS Pharma
  • Hypermarcas
  • Eurofarma
  • Teuto Brasileiro
  • Biolab Farmaceutica
  • Cristalia
  • União Quimica
  • Boehringer Ingelheim
  • Mantecorp Farmasa
  • Libbs
  • Cimed
  • FQM Grupo
  • Spimaco
  • Jamjoom Pharma
  • Tabuk Pharmaceutical Manufacturing
  • Jazeera Pharmaceutical Industries
  • Apotex
  • Adcock Ingram
  • Eurolab
  • Ranbaxy (Pty) Ltd
  • Aspen

      • Table Of Contents

      1. Generic Pharmaceuticals Market Executive Summary

      2. Table of Contents

      3. List of Figures

      4. List of Tables

      5. Report Structure

      6. Introduction

      6.1. Segmentation By Geography

      6.2. Segmentation By Therapy

      6.3. Segmentation By Distribution Channel

      6.4. Segmentation By Type

      6.5. Segmentation By Drug Delivery

      7. Generic Pharmaceuticals Market Characteristics

      7.1. Segmentation By Therapy

      7.1.1. CNS

      7.1.2. Cardiovascular

      7.1.3. Dermatology

      7.1.4. Genitourinary/Harmonal

      7.1.5. Respiratory

      7.1.6. Rheumatology

      7.1.7. Diabetes

      7.1.8. Oncology

      7.1.9. Biosimilars

      7.1.10. Others

      7.2. Segmentation By Distribution Channel

      7.2.1. Hospital Pharmacies

      7.2.2. Retail Pharmacies

      7.2.3. Online Pharmacies

      7.3. Segmentation By Type

      7.3.1. Biosimilar

      7.3.2. Generics

      7.4. Segmentation By Drug Delivery Method

      7.4.1. Oral

      7.4.2. Injectables

      7.4.3. Dermal/Topical

      7.4.4. Inhaled

      8. Generic Pharmaceuticals Market Trends And Strategies

      8.1. Use of Biomarkers for Drug Development

      8.2. New Product Launches

      8.3. Investment in Artificial Intelligence

      8.4. Collaboration Driving Innovation

      8.5. Combination Drug Therapy

      8.6. 3D Printing Technology

      8.7. Modification Of Existing Epilepsy Drugs

      8.8. Rise Of Generic Respiratory Drugs

      9. Impact Of COVID-19 On Generic Pharmaceuticals Market

      9.1. Introduction

      9.2. Impact Of COVID-19 on Supply Chain Issues

      9.3. Impact Of COVID-19 Leading To Induced Demand And Panic Buying

      9.4. Impact Of COVID-19 On Companies

      9.5. Future Outlook

      10. Global Generic Pharmaceuticals Market Size And Growth

      10.1. Market Size

      10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

      10.2.1. Drivers Of The Market 2015 – 2020

      10.2.2. Restraints On The Market 2015 – 2020

      10.3.Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      10.3.1. Drivers Of The Market 2020 – 2025

      10.3.2. Restraints On The Market 2020 – 2025

      11. Global Generic Pharmaceuticals Market Segmentation

      11.1. Global Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.2. Global Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.3. Global Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.4.Global Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      12. Generic Pharmaceuticals Market, Regional And Country Analysis

      12.1. Global Generic Pharmaceuticals Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      12.2. Global Generic Pharmaceuticals Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13. Asia-Pacific Generic Pharmaceuticals Market

      13.1. Asia-Pacific Generic Pharmaceuticals Market Overview

      13.1.1. Region Information

      13.1.2. Market Information

      13.1.3. Background Information

      13.1.4. Government Initiatives

      13.1.5. Regulations

      13.1.6. Regulatory Bodies

      13.1.7. Major Associations

      13.1.8. Taxes Levied

      13.1.9. Corporate Tax Structure

      13.1.10. Investments

      13.1.11. Major Companies

      13.2. Asia-Pacific Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.3. Asia-Pacific Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.4.Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.5. Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.6.Asia-Pacific Generic Pharmaceuticals Market: Country Analysis

      13.7. China Generic Pharmaceuticals Market

      13.8.China Generic Pharmaceuticals Market Overview

      13.8.1. Country Information

      13.8.2. Market Information

      13.8.3. Background Information

      13.8.4. Government Initiatives

      13.8.5. Regulations

      13.8.6. Regulatory Bodies

      13.8.7. Major Associations

      13.8.8. Taxes Levied

      13.8.9. Corporate Tax Structure

      13.8.10. Investments

      13.8.11. Major Companies

      13.9.China Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.10. China Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.11. China Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.12. China Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.13. India Generic Pharmaceuticals Market

      13.14. India Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.15. India Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.16. India Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.17. India Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.18. Japan Generic Pharmaceuticals Market

      13.19. Japan Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.20. Japan Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.21. Japan Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.22. Japan Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.23. Australia Generic Pharmaceuticals Market

      13.24. Australia Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.25. Australia Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.26. Australia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.27. Australia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.28. Indonesia Generic Pharmaceuticals Market

      13.29. Indonesia Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.30. Indonesia Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.31. Indonesia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.32. Indonesia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.33. South Korea Generic Pharmaceuticals Market

      13.34. South Korea Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.35. South Korea Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.36. South Korea Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.37. South Korea Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14. Western Europe Generic Pharmaceuticals Market

      14.1.Western Europe Generic Pharmaceuticals Market Overview

      14.1.1. Region Information

      14.1.2. Market Information

      14.1.3. Background Information

      14.1.4. Government Initiatives

      14.1.5. Regulations

      14.1.6. Regulatory Bodies

      14.1.7. Major Associations

      14.1.8. Taxes Levied

      14.1.9. Corporate Tax Structure

      14.1.10. Investments

      14.1.11. Major Companies

      14.2. Western Europe Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.3.Western Europe Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      14.4. Western Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.5. Western Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.6. Western Europe Generic Pharmaceuticals Market: Country Analysis

      14.7. UK Generic Pharmaceuticals Market

      14.8. UK Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.9. UK Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      14.10. UK Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.11. UK Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.12. Germany Generic Pharmaceuticals Market

      14.13. Germany Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.14. Germany Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      14.15. Germany Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.16. Germany Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.17. France Generic Pharmaceuticals Market

      14.18. France Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.19. France Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      14.20. France Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.21. France Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15. Eastern Europe Generic Pharmaceuticals Market

      15.1. Eastern Europe Generic Pharmaceuticals Market Overview

      15.1.1. Region Information

      15.1.2. Market Information

      15.1.3. Background Information

      15.1.4. Government Initiatives

      15.1.5. Regulations

      15.1.6. Regulatory Bodies

      15.1.7. Major Associations

      15.1.8. Taxes Levied

      15.1.9. Corporate Tax Structure

      15.1.10. Investments

      15.1.11. Major Companies

      15.2. Eastern Europe Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      15.3. Eastern Europe Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      15.4. Eastern Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.5. Eastern Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.6. Eastern Europe Generic Pharmaceuticals Market: Country Analysis

      15.7. Russia Generic Pharmaceuticals Market

      15.8. Russia Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      15.9. Russia Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      15.10. Russia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.11. Russia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16. North America Generic Pharmaceuticals Market

      16.1.North America Generic Pharmaceuticals Market Overview

      16.1.1. Region Information

      16.1.2. Market Information

      16.1.3. Background Information

      16.1.4. Government Initiatives

      16.1.5. Regulations

      16.1.6. Regulatory Bodies

      16.1.7. Major Associations

      16.1.8. Taxes Levied

      16.1.9. Corporate Tax Structure

      16.1.10. Investments

      16.1.11. Major Companies

      16.2. North America Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      16.3.North America Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      16.4. North America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.5. North America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.6. North America Generic Pharmaceuticals Market: Country Analysis

      16.7. USA Generic Pharmaceuticals Market

      16.8. USA Generic Pharmaceuticals Market Overview

      16.8.1. Country Information

      16.8.2. Market Information

      16.8.3. Background Information

      16.8.4. Government Initiatives

      16.8.5. Regulations

      16.8.6. Regulatory Bodies

      16.8.7. Major Associations

      16.8.8. Taxes Levied

      16.8.9. Corporate Tax Structure

      16.8.10.Investments

      16.8.11. Major Companies

      16.9. USA Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      16.10. USA Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      16.11. USA Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.12. USA Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17. South America Generic Pharmaceuticals Market

      17.1. South America Generic Pharmaceuticals Market Overview

      17.1.1. Region Information

      17.1.2. Market Information

      17.1.3. Background Information

      17.1.4. Government Initiatives

      17.1.5. Regulations

      17.1.6. Regulatory Bodies

      17.1.7. Major Associations

      17.1.8. Taxes Levied

      17.1.9. Corporate Tax Structure

      17.1.10. Investments

      17.1.11. Major Companies

      17.2. South America Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.3. South America Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      17.4. South America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.5. South America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.6. South America Generic Pharmaceuticals Market: Country Analysis

      17.7. Brazil Generic Pharmaceuticals Market

      17.8. Brazil Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.9. Brazil Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      17.10. Brazil Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.11. Brazil Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18. Middle East Generic Pharmaceuticals Market

      18.1. Middle East Generic Pharmaceuticals Market Overview

      18.1.1. Region Information

      18.1.2. Market Information

      18.1.3. Background Information

      18.1.4. Government Initiatives

      18.1.5. Regulations

      18.1.6. Regulatory Bodies

      18.1.7. Major Associations

      18.1.8. Taxes Levied

      18.1.9. Corporate Tax Structure

      18.1.10. Investments

      18.1.11. Major Companies

      18.2. Middle East Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.3.Middle East Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      18.4. Middle East Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18.5. Middle East Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19. Africa Generic Pharmaceuticals Market

      19.1.Africa Generic Pharmaceuticals Market Overview

      19.1.1. Region Information

      19.1.2. Market Information

      19.1.3. Background Information

      19.1.4. Government Initiatives

      19.1.5. Regulations

      19.1.6. Regulatory Bodies

      19.1.7. Major Associations

      19.1.8. Taxes levied

      19.1.9. Corporate Tax Structure

      19.1.10. Investments

      19.1.11. Major Companies

      19.2. Africa Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.3.Africa Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      19.4. Africa Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19.5. Africa Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      20. Generic Pharmaceuticals Global Market Competitive Landscape

      20.1. Company Profiles

      20.2. Teva Pharmaceutical Industries Ltd.

      20.2.1. Company Overview

      20.2.2. Products And Services

      20.2.3. Business Strategy

      20.2.4. Financial Overview

      20.3. Novartis AG

      20.3.1. Company Overview

      20.3.2. Products And Services

      20.3.3. Business Strategy

      20.3.4. Financial Overview

      20.4. Viatris Inc.

      20.4.1. Company Overview

      20.4.2. Products And Services

      20.4.3. Business Strategy

      20.4.4. Financial Overview

      20.5. Sun Pharmaceutical Industries Ltd.

      20.5.1. Company Overview

      20.5.2. Products And Services

      20.5.3. Business Strategy

      20.5.4. Financial Overview

      20.6. Fresenius Kabi

      20.6.1. Company Overview

      20.6.2. Products And Services

      20.6.3. Business Strategy

      20.6.4. Financial Overview

      21. Key Mergers And Acquisitions In The Generic Pharmaceuticals Market

      21.1. Carlyle Acquired Viyash Life Sciences

      21.2. Sandoz Acquired GSK’s Cephalosporin Antibiotics Business

      21.3. ANI Pharmaceuticals, Inc. Acquired Novitium Pharma

      21.4. Mylan NV Merged With Viatris

      21.5. Sun Pharmaceutical Industries Acquired Aquinox Pharmaceuticals Inc.

      21.6. ANI Pharmaceuticals, Inc. Acquired Amerigen Pharmaceuticals, Ltd. Generic Products

      21.7. Sandoz Acquired Aspen Global Incorporated (AGI)

      21.8. Teva Pharmaceutical Industries Ltd. Acquired Allergan plc

      21.9. Sun Pharma Acquired Ranbaxy Laboratories

      21.10. Pfizer Inc. Merged With Hospira, Inc.

      22. Generic Pharmaceuticals Market Future Outlook and Potential Analysis

      22.1. Global Generic Pharmaceuticals Market In 2025 – Countries Offering Most New Opportunities

      22.2. Global Generic Pharmaceuticals Market In 2025 – Segments Offering Most New Opportunities

      22.3. Global Generic Pharmaceuticals Market In 2025 – Growth Strategies

      22.3.1. Market Trend Based Strategies

      22.3.2. Competitor Strategies

      23. Appendix

      23.1. Market Data Sources

      23.2. NAICS Definitions Of Industry Covered In This Report

      23.3.Research Methodology

      23.4. Abbreviations

      23.5. Currencies

      23.6. Research Inquiries

      23.7. The Business Research Company

      23.8. Copyright And Disclaimer

    List Of Tables

      Table 1: Global Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 2: Global Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 3: Global Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 4: Global Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 5: Global Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 6: Global Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 7: Global Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 8: Global Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 9: Global Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 10: Global Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 11: Global Generic Pharmaceuticals Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 12: Global Generic Pharmaceuticals Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 13: Global Generic Pharmaceuticals Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 14: Global Generic Pharmaceuticals Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 15: Asia-Pacific Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 16:  Asia-Pacific Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 17: Asia-Pacific, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 18: Asia Pacific Healthcare Services Market Size, Historic And Forecast, 2015-2020, 2020-2025F, 2030F
    • Table 19: Asia Pacific GDP Per Capita, 2015-2020, $
    • Table 20: Asia-Pacific Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 21: Asia-Pacific Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 22: Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 23: Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 24: Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 25: Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 26:  China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 27: China, Population By Age Group, 2015-2025, Thousands
    • Table 28: China Healthcare Services Market Size, Historic And Forecast, 2015-2020, 2020-2025F, 2030F
    • Table 29: China GDP Per Capita, 2015-2020, $
    • Table 30: China Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 31: China Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 32: China Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 33: China Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 34: China Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 35: China Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 36: India Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 37: India Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 38: India Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 39: India Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 40: India Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 41: India Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 42: Japan Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 43: Japan Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 44: Japan Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 45: Japan Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 46: Japan Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 47: Japan Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 48: Australia Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 49: Australia Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 50: Australia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 51: Australia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 52: Australia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 53: Australia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 54: Indonesia Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 55: Indonesia Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 56: Indonesia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 57: Indonesia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 58: Indonesia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 59: Indonesia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 60: South Korea Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 61: South Korea Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 62: South Korea Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 63: South Korea Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 64: South Korea Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 65: South Korea Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 66:  Western Europe Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 67:  Western Europe Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 68: Western Europe, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 69: Western Europe Healthcare Services Market Size, Historic And Forecast, 2015-2020, 2020-2025F, 2030F
    • Table 70: Western Europe GDP Per Capita, 2015-2020, $
    • Table 71: Western Europe Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 72: Western Europe Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 73: Western Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 74: Western Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 75: Western Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 76: Western Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 77: UK Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 78: UK Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 79: UK Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 80: UK Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 81: UK Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 82: UK Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 83: Germany Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 84: Germany Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 85: Germany Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 86: Germany Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 87: Germany Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 88: Germany Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 89: France Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 90: France Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 91: France Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 92: France Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 93: France Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 94: France Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 95:  Eastern Europe Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 96:  Eastern Europe Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 97: Eastern Europe, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 98: Eastern Europe Healthcare Services Market Size, Historic And Forecast, 2015-2020, 2020-2025F, 2030F
    • Table 99: Eastern Europe GDP Per Capita, 2015-2020, $
    • Table 100: Eastern Europe Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 101: Eastern Europe Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 102: Eastern Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 103: Eastern Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 104: Eastern Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 105: Eastern Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 106: Russia Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 107: Russia Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 108: Russia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 109: Russia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 110: Russia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 111: Russia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 112:  North America Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 113:  North America Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 114: North America, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 115: North America Healthcare Services Market Size, Historic And Forecast, 2015-2020, 2020-2025F, 2030F
    • Table 116: North America GDP Per Capita, 2015-2020, $
    • Table 117: North America Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 118: North America Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 119: North America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 120: North America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 121: North America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 122: North America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 123:  USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 124: USA, Population By Age Group, 2015-2025, Thousands
    • Table 125: USA Healthcare Services Market Size, Historic And Forecast, 2015-2020, 2020-2025F, 2030F
    • Table 126: USA GDP Per Capita, 2015-2020, $
    • Table 127: USA Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 128: USA Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 129: USA Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 130: USA Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 131: USA Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 132: USA Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 133:  South America Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 134:  South America Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 135: South America, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 136: South America Healthcare Services Market Size, Historic And Forecast, 2015-2020, 2020-2025F, 2030F
    • Table 137: South America GDP Per Capita, 2015-2020, $
    • Table 138: South America Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 139: South America Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 140: South America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 141: South America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 142: South America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 143: South America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 144: Brazil Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 145: Brazil Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 146: Brazil Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 147: Brazil Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 148: Brazil Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 149: Brazil Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 150:  Middle East Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 151:  Middle East Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 152: Middle East, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 153: Middle East Healthcare Services Market Size, Historic And Forecast, 2015-2020, 2020-2025F, 2030F
    • Table 154: Middle East GDP Per Capita, 2015-2020, $
    • Table 155: Middle East Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 156: Middle East Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 157: Middle East Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 158: Middle East Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 159: Middle East Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 160: Middle East Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 161:  Africa Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 162:  Africa Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 163: Africa, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 164: Africa Healthcare Services Market Size, Historic And Forecast, 2015-2020, 2020-2025F, 2030F
    • Table 165: Africa GDP Per Capita, 2015-2020, $
    • Table 166: Africa Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 167: Africa Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 168: Africa Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 169: Africa Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 170: Africa Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 171: Africa Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 172: Global Generic Pharmaceuticals Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Table 173: Teva Pharmaceutical Industries Ltd. – Financial Overview, 2016 - 2020, $ Billion
    • Table 174: Novartis AG – Financial Performance, 2016 – 2020, $ Billion
    • Table 175: Viatris Inc. – Financial Performance, 2016 – 2020, $ Billion
    • Table 176: Sun Pharmaceutical Industries Ltd. – Financial Overview, 2016 - 2020, $ Billion
    • Table 177: Fresenius Kabi  – Financial Overview, 2016 - 2020, $ Billion
    • Table 178: Global Generic Pharmaceuticals Market Size Gain ($ Million), 2020 – 2025, By Country
    • Table 179: Global Generic Pharmaceuticals Market Size Gain ($ Million), Segmentation By Therapy, 2020 – 2025
    • Table 180: Global Generic Pharmaceuticals Market Size Gain ($ Million), Segmentation By Distribution Channel, 2020 – 2025
    • Table 181: Global Generic Pharmaceuticals Market Size Gain ($ Million), Segmentation By Type, 2020 – 2025
    • Table 182: Global Generic Pharmaceuticals Market Size Gain ($ Million), Segmentation By Drug Delivery, 2020 – 2025
    • Table 183: Generic Pharmaceuticals - Market Data Sources

    List Of Figures

      Figure 1: Global Generic Pharmaceuticals Market Segmentation By Therapy
    • Figure 2: Global Generic Pharmaceuticals Market Segmentation By Distribution Channel
    • Figure 3: Global Generic Pharmaceuticals Market Segmentation By Type
    • Figure 4: Global Generic Pharmaceuticals Market Segmentation By Drug Delivery
    • Figure 5: Global Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 6: Global Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 7: Global Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 8: Global Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 9: Global Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 10: Global Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 11: Global Generic Pharmaceuticals Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 12: Global Generic Pharmaceuticals Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 13: Asia-Pacific Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 14: Asia-Pacific Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 15: Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 16: Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 17: China Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 18: China Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 19: China Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 20: China Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 21: India Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 22: India Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 23: India Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 24: India Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 25: Japan Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 26: Japan Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 27: Japan Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 28: Japan Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 29: Australia Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 30: Australia Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 31: Australia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 32: Australia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 33: Indonesia Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 34: Indonesia Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 35: Indonesia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 36: Indonesia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 37: South Korea Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 38: South Korea Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 39: South Korea Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 40: South Korea Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 41: Western Europe Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 42: Western Europe Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 43: Western Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 44: Western Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 45: UK Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 46: UK Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 47: UK Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 48: UK Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 49: Germany Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 50: Germany Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 51: Germany Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 52: Germany Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 53: France Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 54: France Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 55: France Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 56: France Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 57: Eastern Europe Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 58: Eastern Europe Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 59: Eastern Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 60: Eastern Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 61: Russia Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 62: Russia Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 63: Russia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 64: Russia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 65: North America Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 66: North America Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 67: North America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 68: North America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 69: USA Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 70: USA Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 71: USA Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 72: USA Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 73: South America Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 74: South America Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 75: South America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 76: South America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 77: Brazil Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 78: Brazil Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 79: Brazil Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 80: Brazil Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 81: Middle East Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 82: Middle East Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 83: Middle East Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 84: Middle East Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 85: Africa Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 86: Africa Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 87: Africa Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 88: Africa Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 89: Global Generic Pharmaceuticals Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Figure 90: Teva Pharmaceutical Industries Ltd. – Financial Overview, 2016 – 2020, $ Billion
    • Figure 91: Novartis AG – Financial Performance, 2016 – 2020, $ Billion
    • Figure 92: Viatris Inc. – Financial Performance, 2016 – 2020, $ Billion
    • Figure 93: Sun Pharmaceutical Industries Ltd. – Financial Overview, 2016 – 2020, $ Billion
    • Figure 94: Fresenius Kabi – Financial Overview, 2016 – 2020, $ Billion
    Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
    Read More
    Global Gene Therapy Market 2022 – Market Opportunities And Strategies
    Read More
    The Microbiome Market Share, Market Size, And Growth Rate 2022
    Read More
    Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
    Read More
    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
    Read More
    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
    Read More
    The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
    Read More
    The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
    Read More
    Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Intravenous, Intranasal/ Inhalation), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter Drugs, Prescription-Based Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Cancer, Cervical Cancer, Blood Cancer, Other Oncology Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/Drug Stores, Other Distribution Channels), By Route Of Administration (Oral, Parental, Other Route Of Administration), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2032
    View Report
    Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies) By Delivery System (Liquid, Gel, Ointment) And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Enzymes Global Market Report 2024 – By Product Type (Asparaginase, Lipase, Protease, Nattokinase, Chitinase, Serratiopeptidase, Collagenase, Ligase, Other Products), By Application (Leukemia, Stomach Disorders, Antitumor, Skin Ulcers, Gaucher Disease, Fabry Disease, Other Applications), By End User (Drug Manufacturers, Hospitals, Private Clinics, Research Laboratories) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    Protein Inhibitors Global Market Report 2024 – By Product (Protein Kinase Inhibitors, Monoclonal Antibody, Other Products), By Application (Oncology, Inflammatory Diseases, Other Applications), By Distribution Channel (Hospital Pharmacies, Independent Pharmacies, Online Pharmacies ) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    Antisense & RNAi Therapeutics Global Market Report 2024 – By Technology (RNA Interference, Antisense RNA), By Route of Administration (Intravenous Injections, Intra-dermal Injections, Other Delivery Methods), By Indication (Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Neurological Disorders, Infectious Diseases, Other Indications) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    Gene Therapy Global Market Report 2024 – By Gene Therapy Type (Germline Therapy, Somatic Cell Therapy), By Vector (Viral Vector, Non-Viral Vector), By Application (Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders), By End Users (Biopharmaceutical Companies, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
    View Report